Guardant Health (GH) investors have a new number to think about this week.  Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175.

A single blood draw added to routine cancer screenings found roughly seven times more cancers than standard tests alone, ...

Sun, Jul 5, 2026 Countryfile presenter Julia Bradbury shared an update on her health after taking a test to find out the ...

The ultra-sensitive test can find hidden signs of pancreatic cancer by looking for a key KRAS genetic mutation missed by ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at ...

I enrolled in Human Longevity's executive health program. My cancer results were reassuring, but my genetic results left me a ...

For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...

Grail is awaiting an FDA ruling on a cancer screening test, but already more tests are finding their way into medical ...

Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert ...

New blood test makes pancreatic cancer easier to detect A new blood test detects pancreatic cancer in 65% of patients, up from 17% with the previous test. Northwestern Medicine Oncologist Dr. Akhil ...

Prostate cancer is the most common cancer among men after skin cancer, according to the American Cancer Society.

Scientists say it has the potential to extend lives by helping doctors identify patients whose disease is more likely to ...